Free Shipping On All Orders
Last Updated: 08.12.24
Please read this document thoroughly, including the Consent to Semaglutide and Tirzepatide, which considers important risks and benefits of these medications.
By using the GobyMeds platform, your telemedicine visits will be furnished by Beluga Health, P.A. (“Beluga”). By engaging in telemedicine visits with a Beluga healthcare practitioner licensed in your state, you agree to the following terms. All visits are asynchronous unless real-time synchronous telemedicine is required by state law.
By clicking the checkbox agreeing to these terms during your GobyMeds account creation, you agree to the Beluga Asynchronous Telemedicine Informed Consent located here, and you acknowledge and agree to the following:
I HAVE READ AND UNDERSTAND THE TERMS PRESENTED OR LINKED TO HEREIN AND GIVE MY INFORMED CONSENT TO PARTICIPATE IN ASYNCHRONOUS TELEMEDICINE (OR REAL-TIME SYNCHRONOUS TELEMEDICINE IF REQUIRED BY STATE LAW).
Below are some of the potential benefits and risks to Semaglutide and Tirzepatide medications so you can make an informed decision.
During your telemedicine visit, a licensed provider will evaluate your medical history, medications, and other information to determine if Semaglutide or Tirzepatide is appropriate for you.
General safety information about these drugs is found below, and more detailed safety information can be found via links on our Safety Information page located here. It is your responsibility to review and consider all safety information with a qualified healthcare professional before consenting to treatment with these or any medications.
Semaglutide:
Semaglutide is a GLP-1 receptor agonist that helps control blood sugar levels and promotes a feeling of fullness by slowing down digestion.
Ozempic® and Wegovy® are brand names for Semaglutide, with Wegovy® being FDA-approved for weight loss.
Compounded Semaglutide is not FDA-approved and is used on a research basis only.
Tirzepatide:
Tirzepatide is a GIP and GLP-1 receptor agonist that regulates gut hormones, reduces blood sugar levels, and promotes fullness.
Mounjaro® (Zepbound®) is the FDA-approved brand name for Tirzepatide for obesity.
Compounded Tirzepatide is not FDA-approved and is used on a research basis.
Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and more.
Serious side effects may include:
Thyroid tumors or cancer
Diabetic retinopathy
Pancreatitis
Gallbladder problems
Hypoglycemia
Kidney problems
Serious allergic reactions
Increased heart rate
Depression or thoughts of suicide
Contraindications and Additional Information:
Do not use Semaglutide and Tirzepatide with other GLP-1 receptor agonists or weight loss products.
Avoid if you have a history of thyroid cancer or multiple endocrine neoplasia type 2.
Stop using these medications three months before pregnancy and avoid during breastfeeding.
You have read and understand the potential side effects and risks.
You will remain under the care of your primary medical provider for all other conditions.
No guarantees of weight loss results.
Compounded medications are not FDA-approved.
No refunds.
You will truthfully disclose all health information requested.
You will follow dosage and administration instructions and not share needles.
By clicking the checkbox agreeing to these terms during your GobyMeds account creation, you confirm that you understand and agree to the information provided, accept all risks associated with Semaglutide and/or Tirzepatide, and consent to proceed with treatment.
You explicitly consent to GobyMeds or its healthcare practitioners and medical partners contacting you via calls, emails, or text messages (both SMS and MMS) concerning Personal Information and Sensitive Information (as defined in the GobyMeds Privacy Policy), appointments, or other matters related to your telemedicine encounters using the contact details you have provided. These communications may be made using an auto-dialer or pre-recorded/artificial voice, even if your number is listed on a do-not-call registry. Standard rates from your phone carrier may apply. You may withdraw this consent at any time by emailing support@gobymeds.com.
This Telemedicine Informed Consent remains valid throughout your treatment with GobyMeds.
We reserve the right to change this Notice and will post the revised Notice on our website.
